Cargando…
Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation Therapy
PURPOSE: Historically, opaque health care pricing in the US has prevented patients from identifying opportunities to lower costs. Attempting to promote price transparency, the US government recently mandated that hospitals publish prices for all services in a document called a chargemaster. Patients...
Autores principales: | Prasad, Rahul N., Yildiz, Vedat O., Patel, Tejash, Royce, Trevor J., Palmer, Joshua D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767260/ https://www.ncbi.nlm.nih.gov/pubmed/35071832 http://dx.doi.org/10.1016/j.adro.2021.100816 |
Ejemplares similares
-
Development of a Financial Toxicity Screening Tool for Radiation Oncology: A Secondary Analysis of a Pilot Prospective Patient-Reported Outcomes Study
por: Prasad, Rahul N., et al.
Publicado: (2021) -
Cardiovascular Event Reporting in Modern Cancer Radiation Therapy Trials
por: Prasad, Rahul N., et al.
Publicado: (2021) -
Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021) -
Financial Toxicity as an End Point in Prospective Clinical Trials Involving Radiation Therapy
por: Prasad, Rahul N., et al.
Publicado: (2022) -
Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Margins
por: Patel, Ankur K., et al.
Publicado: (2020)